When talking about dementia, people usually refer to senile dementia or Alzheimer’s disease. One large group of similar conditions had been diagnosed with Alzheimer’s disease or as psychiatric conditions until frontotemporal dementia was recognized as a specific entity. The term frontotemporal lobar degeneration includes a group of disorders affecting frontal and temporal lobe of the brain, leading to atrophy and shrinking of these regions. These areas are associated with your behavior, language, and personality features. Thus frontotemporal dementia presents as various signs and symptoms.
It affects both gender between the ages of 45 and 75 and it usually starts as a significant change in behavior, social disinhibition, troubles speaking, impulsiveness or emotional flat line and many other cognitive disorders.
To gather knowledge, skills and unite power to fight this issue, the scientific community established ICFTD – International Conference on Frontotemporal Dementias.
Thirty years old concept
Back in 1986, Sweden held the first International Conference on Frontotemporal Dementias, as well as three next meetings on the same subject. The Conference included three days of scientific congress and one day reserved for Caregivers Session. It was organized in every two years at various locations, including European countries and North America. After several years of spontaneous organizing without clear and regular concept, leading scientists decided to establish ISFTD as an international entity in charge of organizing, financing and hosting meetings regularly every two years in one chosen country. Ninth Conference took place in Vancouver in 2014 and Munich was chosen to host the tenth, special Conference two years later.
Vancouver hosted over 600 experts
Several hundreds of delegates and experts in various scientific fields took part in 9th Conference on Frontotemporal Dementias held in Vancouver in 2014. The audience included clinicians, neuroscientists, pharmaceutics, students, various government agencies, patients suffering FTD and their families, different profiles of caregivers and many other laymen interested in this field of medicine. The Conference was a perfect environment and occasion for everyone included in researching, studying, treating, dealing and living with these neurodegenerative diseases to unite their knowledge, experience, and ideas. Three main goals were set: to gather and exchange the pool of information and present overall knowledge on the matter; to evaluate currently applied therapies and come up with the fresh ideas for some new approaches in treatment; to connect the scientific community with patients and their families suffering FTD.
Three days of the Conference were dedicated to lectures, experiments, presentations, and debates where clinicians, researchers and everyone else included explored current research evidence, knowledge and conclusions about FTD, trends in this field and experiences with current treatments. Many new ideas and hypotheses emerged, any connections and collaborations were established, experiences shared and new courses for improving medical care for these patients were set.
The last day was dedicated to Caregiver Session. This was practical training including patients, their families, clinicians, and nurses.
Conference in Vancouver showed significant progress in understanding and treating neurodegenerative diseases, and the results revealed dramatic improvement in the quality of everyday’s life of these patients. The next meeting is set for 2016 in Munich, and it is expected to gather over thousand experts. Abstract publications were released and published in Journal of Neurochemistry. It holds a lot of useful information for everyone interested in taking part in 10th International Conference on FTD.